Shanghai HeartCare Medical Technology Corporation Limited (6609.HK) HKSE
48.16
+0.1(+0.21%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
48.16
+0.1(+0.21%)
Currency In HKD
Sector
Healthcare
Industry
Medical - Devices
Employees
344
First IPO Date
August 20, 2021
| Name | Title | Pay | Year Born |
| Guohui Wang | Chairman & Chief Executive Officer | 1.82M | 1979 |
| Kun Zhang | Executive Director | 1.18M | 1979 |
| Jiawei Wei | Deputy GM & Executive Director | 1.71M | 1979 |
| Han Zhang | Chief Financial Officer & Joint Company Secretary | 0 | 1987 |
| Siu Ying Kwok | Joint Company Secretary | 0 | 1985 |
Shanghai HeartCare Medical Technology Corporation Limited engages in the research, development, manufacture, and sale of neuro-interventional medical devices worldwide. The company offers ischemic stroke thrombectomy, intracranial stenosis treatment, ischemic stroke prevention, hemorrhagic stroke treatment, and vascular access devices. Its products are used for the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis, as well as for the treatment of hemorrhagic stroke. The company was formerly known as Shanghai Care Medical Technology Corporation Limited. Shanghai HeartCare Medical Technology Corporation Limited was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.